{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:23:45Z","timestamp":1791073425680,"version":"4.1.0"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2009,7,31]],"date-time":"2009-07-31T00:00:00Z","timestamp":1248998400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0006465","type":"journal-article","created":{"date-parts":[[2009,7,30]],"date-time":"2009-07-30T21:48:10Z","timestamp":1248990490000},"page":"e6465","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":126,"title":["Evaluation of RTS,S\/AS02A and RTS,S\/AS01B in Adults in a High Malaria Transmission Area"],"prefix":"10.1371","volume":"4","clinical-trial-number":[{"clinical-trial-number":"nct00197054","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Mark E.","family":"Polhemus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shon A.","family":"Remich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhards R.","family":"Ogutu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John N.","family":"Waitumbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Otieno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Apollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James F.","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent E.","family":"Kester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian F.","family":"Ockenhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Opokua","family":"Ofori-Anyinam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Ramboer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor P.","family":"Cahill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Lievens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claude","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Ange","family":"Demoitie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Leach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Ripley","family":"Ballou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Gray","family":"Heppner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2009,7,31]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature03342","article-title":"The global distribution of clinical episodes of malaria.","volume":"434","author":"RW Snow","year":"2005","journal-title":"Nature"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/S0140-6736(05)66420-3","article-title":"Malaria.","volume":"365","author":"BM Greenwood","year":"2005","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4269\/ajtmh.2001.64.1","article-title":"The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden.","volume":"64","author":"JG Breman","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4269\/ajtmh.2004.71.141","article-title":"The Malaria Gap.","volume":"71","author":"P Malaney","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4269\/ajtmh.2006.75.131","article-title":"Predicting the cost-effectiveness of introducing a pre-erythrocytic malaria vaccine into the expanded program on immunization in Tanzania.","volume":"75","author":"F Tediosi","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1473-3099(04)01043-6","article-title":"The global distribution and population at risk of malaria: past, present, and future.","volume":"4","author":"SI Hay","year":"2004","journal-title":"Lancet Inf Dis"},{"key":"ref7","article-title":"State of the art of vaccine research and development: Initiative for vaccine research World Health Organization, January 2005."},{"key":"ref8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1586\/14760584.2.2.231","article-title":"Development of RTS,S\/AS02: a purified subunit-based malaria vaccine candidate formulated with a novel adjuvant.","volume":"2","author":"N Gar\u00e7on","year":"2003","journal-title":"Expert Rev Vaccines"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/978-1-4615-1823-5_21","article-title":"Monophosphoryl liquid A as an adjuvant. Past experiences and new directions.","volume":"6","author":"JT Ulrich","year":"1995","journal-title":"Pharm Biotechnol"},{"key":"ref10","first-page":"1","article-title":"Saponins as vaccine adjuvants.","volume":"13(1\u20132)","author":"CR Kensil","year":"1996","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1056\/NEJM199701093360202","article-title":"A preliminary evaluation of a recombinant circumsporozoite protein vaccine against <italic>Plasmodium falciparum<\/italic> malaria.","volume":"336","author":"JA Stoute","year":"1997","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1086\/515657","article-title":"Long term efficacy and immune responses following immunization with the RTS,S malaria vaccine.","volume":"178","author":"JA Stoute","year":"1998","journal-title":"JID"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1086\/315074","article-title":"Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S\/SBAS2, a recombinant <italic>Plasmodium falciparum<\/italic> malaria vaccine.","volume":"180","author":"A Lalvani","year":"1999","journal-title":"JID"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1086\/318534","article-title":"Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental <italic>Plasmodium falciparum<\/italic> malaria.","volume":"183","author":"KE Kester","year":"2001","journal-title":"JID"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.1016\/j.vaccine.2007.05.005","article-title":"A phase I\/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S\/AS02A in malaria-naive adults.","volume":"25","author":"KE Kester","year":"2007","journal-title":"Vaccine"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.vaccine.2008.02.048","article-title":"Phase 2a Trial of 0, 1, 3 month and 0, 7, 28 day immunization schedules of malaria vaccine RTS,S\/AS02 in malaria-na\u00efve adults at the Walter Reed Army Institute of Research.","volume":"26","author":"KE Kester","year":"2008","journal-title":"Vaccine"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"865","DOI":"10.4269\/ajtmh.1999.61.865","article-title":"A phase I safety and immunogenicity trial with the candidate malaria vaccine RTS,S\/SBAS2 in semi-immune adults in The Gambia.","volume":"61","author":"JF Doherty","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(01)06957-4","article-title":"Efficacy of RTS,S\/AS02 malaria vaccine against <italic>Plasmodium falciparum<\/italic> infection in semi-immune adult men in the Gambia: A Randomized Trial.","volume":"358","author":"KA Bojang","year":"2001","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1365-2249.2004.02371.x","article-title":"Cellular immunity induced by the recombinant <italic>Plasmodium falciparum<\/italic> malaria vaccine, RTS,S\/AS02, in semi-immune adults in The Gambia.","volume":"135","author":"M Pinder","year":"2004","journal-title":"Clin Exptl Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"166","DOI":"10.4269\/ajtmh.2006.75.166","article-title":"Phase 1 safety and immunogenicity trial of malaria vaccine RTS,S\/AS02A in adults in a hyperendemic region of Western Kenya.","volume":"75","author":"JA Stoute","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0140-6736(04)17223-1","article-title":"Efficacy of the RTS,S\/AS02A vaccine against <italic>Plasmodium falciparum<\/italic> infection and disease in young African children: randomised controlled trial.","volume":"364","author":"PL Alonso","year":"2004","journal-title":"Lancet"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0140-6736(05)67669-6","article-title":"Duration of protection with RTS,S\/AS02A malaria vaccine in prevention of <italic>Plasmodium falciparum<\/italic> disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial.","volume":"366","author":"PL Alonso","year":"2005","journal-title":"Lancet"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-3156.2006.01754.x","article-title":"Safety, reactogenicity and immunogenicity of the RTS,S\/AS02A candidate malaria vaccine in children aged 1 to 4 years in Mozambique.","volume":"12","author":"E Macete","year":"2007","journal-title":"Trop Med Int Health"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1745-6215-8-11","article-title":"Evaluation of two formulations of adjuvanted RTS, S malaria vaccine in children aged 3 to 5 years living in a malaria-endemic region of Mozambique: a Phase I\/IIb randomized double-blind bridging trial.","volume":"8","author":"EV Macete","year":"2007","journal-title":"Trials"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1016\/j.vaccine.2005.03.019","article-title":"Phase I safety and immunogenicity of RTS,S\/AS02A in children 1 to 10 years of age in The Gambia.","volume":"23","author":"K Bojang","year":"2005","journal-title":"Vaccine"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(07)61542-6","article-title":"Safety of the RTS,S\/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I\/IIb trial.","volume":"370","author":"JJ Aponte","year":"2007","journal-title":"Lancet"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"6493","DOI":"10.1016\/j.vaccine.2006.06.035","article-title":"Cutaneous delayed-type hypersensitivity (DTH) in a multi-formulation comparator trial of the anti-<italic>falciparum<\/italic> malaria vaccine candidate RTS,S in rhesus macaques.","volume":"24","author":"VA Stewart","year":"2006","journal-title":"Vaccine"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"6483","DOI":"10.1016\/j.vaccine.2006.06.033","article-title":"Pre-clinical evaluation of new adjuvant formulations to improve the immunogenicity of the malaria vaccine RTS,S\/AS02A.","volume":"24","author":"VA Stewart","year":"2006","journal-title":"Vaccine"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.vaccine.2007.12.018","article-title":"Improved T cell responses to <italic>Plasmodium falciparum<\/italic> circumsporozoite protein in mice and monkeys induced by a novel formulation of RTS,S vaccine antigen.","volume":"26","author":"P Mettens","year":"2008","journal-title":"Vaccine"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1086\/600120","article-title":"Randomized, Double-Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S\/AS01B and RTS,S\/AS02A in Malaria-Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection.","volume":"200","author":"KE Kester","year":"2009","journal-title":"J Infect Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1056\/NEJMoa0807773","article-title":"Safety and immunogenicity of RTS,S\/AS02D malaria vaccine in infants.","volume":"359","author":"S Adbulla","year":"2008","journal-title":"N Engl J Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1056\/NEJMoa0807381","article-title":"Efficacy of RTS,S\/AS01E vaccine against malaria in children 5 to 17 months of age.","volume":"359","author":"P Bejon","year":"2008","journal-title":"N Engl J Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"6961","DOI":"10.4049\/jimmunol.171.12.6961","article-title":"Protective immunity induced with malaria vaccine, RTS,S, is linked to <italic>Plasmodium falciparum<\/italic> circumsporozoite protein-specific CD4+ and CD8+ T cells producing IFN-gamma.","volume":"171","author":"P Sun","year":"2003","journal-title":"J Immunol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0006465","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T16:03:57Z","timestamp":1710518637000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0006465"}},"subtitle":[],"editor":[{"given":"James G.","family":"Beeson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,7,31]]},"references-count":33,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2009,7,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0006465","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,31]]}}}